Leading Pharma, LLC recalls
1 recall filed under Leading Pharma, LLC. The most recent was published April 29, 2026.
-
Class II · 6 months ago
Leading Pharma, LLC Furosemide Tablets, USP, 80 mg, 100 Tablets bottles recall: CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended
CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
About this page
Leading Pharma, LLC appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.